1. Hepatic hypertrophy and hemodynamics of portal venous flow after percutaneous transhepatic portal embolization
- Author
-
Akinobu Taketomi, Toshiya Kamiyama, Yusuke Sakuhara, Shingo Shimada, Hideki Yokoo, Akihisa Nagatsu, Tatsuhiko Kakisaka, Hirofumi Kamachi, Tatsuya Orimo, Daisuke Abo, and Kenji Wakayama
- Subjects
Male ,medicine.medical_specialty ,Percutaneous ,Portal venous flow ,medicine.medical_treatment ,lcsh:Surgery ,Hemodynamics ,Venous flow ,Muscle hypertrophy ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Internal medicine ,medicine ,Hepatectomy ,Humans ,Embolization ,Percutaneous transhepatic portal embolization ,Hepatic hypertrophy ,Aged ,Ultrasonography ,business.industry ,Portal Vein ,Liver Neoplasms ,General Medicine ,lcsh:RD1-811 ,Hypertrophy ,Organ Size ,Middle Aged ,Embolization, Therapeutic ,Surgery ,Liver Regeneration ,Ultrasound sonography ,chemistry ,Liver ,030220 oncology & carcinogenesis ,Cardiology ,030211 gastroenterology & hepatology ,Female ,Gallbladder Neoplasms ,Liver function ,business ,Tomography, X-Ray Computed ,Indocyanine green ,Research Article ,Liver Circulation - Abstract
Background Percutaneous transhepatic portal embolization (PTPE) is useful for safe major hepatectomy. This study investigated the correlation between hepatic hypertrophy and hemodynamics of portal venous flow by ultrasound sonography after PTPE. Methods We analyzed 58 patients with PTPE, excluding those who underwent recanalization (n = 10). Using CT volumetry results 2 weeks after PTPE, the patients were stratified into a considerable hypertrophy group (CH; n = 15) with an increase rate of remnant liver volume (IR-RLV) ≥ 40% and a minimal hypertrophy group (MH; n = 33) with an IR-RLV
- Published
- 2019